<DOC>
	<DOCNO>NCT01015859</DOCNO>
	<brief_summary>The aim study assess clinical benefit result SafeR comparison standard dual chamber programming ( DDD ) long atrioventricular ( AV ) delay . The benefit assess compare percentage ventricular pacing , incidence atrial arrhythmia , evolution hemodynamic status observe echo parameter atrial natriuretic peptide/brain natriuretic peptide ( ANP/BNP ) measurement .</brief_summary>
	<brief_title>Spontaneous Atrioventricular Conduction Preservation</brief_title>
	<detailed_description />
	<criteria>Any patient fulfil one official guideline implant dualchamber pacemaker ( primoimplantation3 ) may include study . The patient present one follow characteristic include : Permanent complete AV block Permanent atrial and/or ventricular arrhythmia already implant cardioverterdefibrillator ( ICD ) Likely cardiac surgery next six month , mainly : severe coronary artery disease severe valvular disease AV node ablation Refuses sign consent form receive appropriate information Refuses cooperate Not able understand study objective protocol Not available schedule followup With life expectancy le one year Already include another clinical study compete objective CANSAVE R study &lt; 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>AV conduction</keyword>
	<keyword>Atrial fibrillation</keyword>
</DOC>